Area of research
Infectious Diseases · Biomedical Engineering
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, COVID-19 Clinical Research Studies, and Biosensors and Analytical Detection.
Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections
Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery
Plasma cell-free RNA signatures of inflammatory syndromes in children
Adeno-associated virus type 2 in US children with acute severe hepatitis
Longitudinal comparison of the developing gut virome in infants and their mothers
Successful Treatment of <i>Balamuthia mandrillaris</i> Granulomatous Amebic Encephalitis with Nitroxoline
Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C
Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccination
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California
COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme
The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions
A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood
Digital droplet PCR accurately quantifies SARS-CoV-2 viral load from crude lysate without nucleic acid purification
CRISPR–Cas12-based detection of SARS-CoV-2
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays
Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2